BIOMX INC (PHGE) Stock Income Statement
NYSEARCA:PHGE • US09090D5095
6.04 USD
-0.2 (-3.21%)
Last: Mar 12, 2026, 11:29 AM
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 30.92M | 36.44M | 25.35M | 27.22M | 35.46M | |||
| Research and Development | 19.03M | 23.18M | 15.92M | 15.34M | 21.69M | |||
| Selling, General, and Administrative Expenses | 9.63M | 11.78M | 8.65M | 9.46M | 11.27M | |||
| Operating Income | -30.92M | -36.44M | -25.35M | -27.22M | -35.46M | |||
| Interest Income/Expense | 220.00K | 121.00K | -1.10M | -1.15M | -690.00K | |||
| Other Income/Expense | 5.05M | 26.69M | 301.00K | 120.00K | -10.00K | |||
| Non Recurring Items | -10.55M | -8.08M | N/A | N/A | N/A | |||
| Income Before Taxes | -36.19M | -17.71M | -26.15M | -28.25M | -36.16M | |||
| Income Tax | 7.00K | 13.00K | 23.00K | 70.00K | 70.00K | |||
| Net Income | -36.20M | -17.73M | -26.17M | -28.32M | -36.23M | |||
| EBITDA | -28.00M | -34.64M | -24.48M | -24.70M | -32.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -22.19 | -28.02 | -9.69 | -18.02 | -26.46 | |||
| Non GAAP EPS | -24.32 | N/A | -5.30 | -9.40 | -13.90 | |||
| Statistics | ||||||||
All data in USD